Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride for minimizing bowel ileus following ERCP with CO2 insufflation
TCTR20210814001Phase 3Enrolling by invitation
- Sponsor
- Srinagarind Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ileus comparing Prucalopride with Placebo (2 arms). Primary endpoint: Post-ERCP bowel ileus incidence. Started Apr 2021; status: enrolling by invitation.
02
Drugs
prucalopride
03
Conditions
ileus
Beyond the preview
Go deeper on TCTR20210814001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210814001.